Clinical Trial Update: Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment

View source ↗

Summary

A clinical trial evaluating organoid-based drug sensitivity screening to guide treatment for metastatic castration-resistant prostate cancer after first-line th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Castration-resistant Prostate Cancer | Status: RECRUITING